nsCanary™

nsCanary™ is a compact, low-cost device designed for real-time biopsy adequacy assessment.

Tumors are heterogeneous, and determining whether biopsy cores contain diagnostically meaningful cancer during a procedure is challenging. Many institutions rely on Rapid On-Site Evaluation (ROSE), which requires pathologically trained personnel, adds time, and is unavailable in most hospitals.

nsCanary™ provides objective feedback in seconds on the presence of pathologically relevant cancer—before another core is taken. It requires minimal training, no dedicated operator, and fits seamlessly into existing workflows.

Initial applications include pancreatic, biliary, and lung biopsies.